HCATHealth Catalyst, Inc.

Nasdaq healthcatalyst.com


$ 5.70 $ 0.07 (1.24 %)    

Thursday, 18-Apr-2024 15:59:54 EDT
QQQ $ 422.80 $ -2.43 (-0.57 %)
DIA $ 377.76 $ 0.39 (0.1 %)
SPY $ 499.54 $ -1.03 (-0.21 %)
TLT $ 88.82 $ -0.45 (-0.5 %)
GLD $ 220.32 $ 0.75 (0.34 %)
$ 5.695
$ 5.58
$ 5.69 x 400
$ 0.00 x 0
$ 5.55 - $ 5.81
$ 5.51 - $ 14.37
465,587
na
321.3M
$ 1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-22-2024 12-31-2023 10-K
2 11-06-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-12-2020 06-30-2020 10-Q
16 05-13-2020 03-31-2020 10-Q
17 02-28-2020 12-31-2019 10-K
18 11-13-2019 09-30-2019 10-Q
19 08-23-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cantor-fitzgerald-reiterates-overweight-on-health-catalyst-maintains-16-price-target

Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:HCAT) with a Overweight and maintains $16 price tar...

 smart-global-reports-q2-results-joins-health-catalyst-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining by around 0.1% on Wednesday.

 keybanc-downgrades-health-catalyst-to-sector-weight

Keybanc analyst Scott Schoenhaus downgrades Health Catalyst (NASDAQ:HCAT) from Overweight to Sector Weight.

 cantor-fitzgerald-reiterates-overweight-on-health-catalyst-maintains-16-price-target

Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:HCAT) with a Overweight and maintains $16 price tar...

 keybanc-maintains-overweight-on-health-catalyst-lowers-price-target-to-10

Keybanc analyst Scott Schoenhaus maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target from ...

 canaccord-genuity-maintains-buy-on-health-catalyst-lowers-price-target-to-11

Canaccord Genuity analyst Richard Close maintains Health Catalyst (NASDAQ:HCAT) with a Buy and lowers the price target from ...

 health-catalyst-q4-2023-gaap-eps-002-sales-7508m-beat-7360m-estimate

Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.02 per share. The company reported quarterly sales of $75.08 m...

 earnings-scheduled-for-february-22-2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

 health-catalysts-measureable-earns-onc-health-it-certification

Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and se...

 guggenheim-upgrades-health-catalyst-to-buy-announces-14-price-target

Guggenheim analyst Jack Wallace upgrades Health Catalyst (NASDAQ:HCAT) from Neutral to Buy and announces $14 price target.

 evercore-isi-group-upgrades-health-catalyst-to-outperform-raises-price-target-to-11

Evercore ISI Group analyst Elizabeth Anderson upgrades Health Catalyst (NASDAQ:HCAT) from In-Line to Outperform and raises t...

 piper-sandler-maintains-overweight-on-health-catalyst-raises-price-target-to-12

Piper Sandler analyst Jessica Tassan maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and raises the price target f...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION